Dr Frank Waldron-Lynch is a physician scientist and is an honorary fellow of the University of Cambridge. He is also a Consultant Endocrinologist and was principal investigator for the 'DILT1D' and 'DILfrequency' type 1 diabetes clinical research studies which investigated novel immunotherapy for the disease. He is currently based in Basel Switzerland working with Novartis in the area of Translational Immunology and autoimmunity.
I am a research nurse and coordinator working in the Metabolic Research laboratories in the Institute of Metabolic Science, University of Cambridge and I have been working on type 1 & Type 2 diabetes studies alongside Dr Mark Evans & Dr Waldron-Lynch for about 6 years. I also facilitate the CAMEO patient support group for people with type 1 diabetes and am happy to help with any questions you may have regarding our research, how to take part and what we are up to at Cambridge. You can read more about my work on a day to day basis here. Contact me on CamT1D@medschl.cam.ac.uk or +44 (0) 1223 762327.
Dr Simon Bond MA PhD CStat CSci leads the statistics team within Cambridge Clinical Trials Unit, providing advice and services to all phases of trials from initial planning to final analysis and dissemination. He has research interests in early phase and adaptive trial design.
Dr Adrian Mander is the director of the MRC Biostatistics Unit Hub for Trials Methodology Research and leads a programme of research in adaptive clinical trial design. He has been working in area of statistics within clinical trials for over 20 years both in a public sector setting and within a large pharmaceutical company. The emphasis of his work is to translate developments in trial design into practice.
Mark Evans is a Reader of Diabetic Medicine at the Metabolic Research laboratories in the Institute of Metabolic Science, University of Cambridge and an Honorary Consultant Physician at Cambridge University Hospitals NHS Foundation Trust. He specialises in the treatment of type 1 diabetes and hypoglycaemia and is involved in research of novel therapies as well as novel medical devices for both type 1 and type 2 diabetes. Mark is principal investigator for many of the diabetes studies here at Cambridge and is also the research lead for the diabetes service. Mark can be contacted via the contact us page or calling +44 (0)1223 762327.
I am a Surgeon-Scientist and Clinical Fellow in Experimental Medicine and ENT Surgery. My specific research interest is in autoimmune inflammation, lymphoid tissue organisation in Type 1 Diabetes and Sjögren’s syndrome. I have previously been involved with clinical trials for type 1 diabetes, chronic otitis media, Sjögren’s syndrome and neurosurgery. My clinical speciality is Otolaryngology and Head and Neck Surgery.
Dan is the newest member to the team here at the Metabolic Research laboratories - Institute of Metabolic Science, University of Cambridge, and currently coordinates our type 1 and type 2 diabetes studies alongside Dr Mark Evans and Nurse Jane Kennet. Contact Dan on firstname.lastname@example.org or +44 (0) 1223 748472.